Omnibus bill including synthetic nicotine regulation passes House…

US: The 2022 Omnibus Bill passed the House last night. It includes language that would give authority to the FDA to regulate products containing nicotine from any source, also including products containing nicotine not derived from tobacco (synthetic nicotine). In a last-minute discussion, the Covid-19 relief measures were stripped out from the bill in order to pass the budget bill, and » Continue Reading.
I'm already a subscriber

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization